Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RHB-104 Add-On to Interferon Beta-1a in RRMS
NCT01717664Phase 2Completed
- Sponsor
- RedHill Biopharma
- Start
- Jun 2013
- Primary completion
- Dec 2015
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 2 trial of RHB-104 in relapsing-remitting multiple sclerosis (RRMS), sponsored by RedHill Biopharma. Started Jun 2013; status: completed.
02
Drugs
RHB-104
03
Conditions
relapsing-remitting multiple sclerosis (RRMS)
Beyond the preview
Go deeper on NCT01717664.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01717664.